Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System
Cells · 04.01.2023 · 12 (2) · 216
DOI: 10.3390/cells12020216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 04.01.2023. Verfasst von Zaffar Azam und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Immunology, Osteoimmunology & Immunoporosis Lab (TIOIL), Department of Biotechnology, All India Institute of Medical Sciences (AIIMS), …. Hauptthemen laut MEDLINE: Cissus, Osteoporosis, Bone Diseases, Metabolic. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DBT(BT/PR41958/MED/97/524/2021) Govt. of India, UGC-New Delhi-India.
Abstract (Originalsprache)
Osteoporosis is a systemic skeletal disease characterised by low bone mineral density (BMD), degeneration of bone micro-architecture, and impaired bone strength. Cissus quadrangularis (CQ), popularly known as Hadjod (bone setter) in Hindi, is a traditional medicinal herb exhibiting osteoprotective potential in various bone diseases, especially osteoporosis and fractures. However, the cellular mechanisms underpinning its direct effect on bone health through altering the host immune system have never been elucidated. In the present study, we interrogated the osteoprotective and immunoporotic (the osteoprotective potential of CQ via modulating the host immune system) potential of CQ in preventing inflammatory bone loss under oestrogen-deficient conditions. The current study outlines the CQ’s osteoprotective potential under both ex vivo and in vivo (ovariectomized) conditions. Our ex vivo data demonstrated that, in a dose-dependent manner CQ, suppresses the RANKL-induced osteoclastogenesis (p < 0.001) as well as inhibiting the osteoclast functional activity (p < 0.001) in mouse bone marrow cells (BMCs). Our in vivo µ-CT and flow cytometry data further showed that CQ administration improves bone health and preserves bone micro-architecture by markedly raising the proportion of anti-osteoclastogenic immune cells, such as Th1 (p < 0.05), Th2 (p < 0.05), Tregs (p < 0.05), and Bregs (p < 0.01), while concurrently lowering the osteoclastogenic Th17 cells in bone marrow, mesenteric lymph nodes, Peyer’s patches, and spleen in comparison to the control group. Serum cytokine analysis further supported the osteoprotective and immunoporotic potential of CQ, showing a significant increase in the levels of anti-osteoclastogenic cytokines (p < 0.05) (IFN-γ, IL-4, and IL-10) and a concurrent decrease in the levels of osteoclastogenic cytokines (p < 0.05) (TNF-α, IL-6, and IL-17). In conclusion, our data for the first time delineates the novel cellular and immunological mechanism of the osteoprotective potential of CQ under postmenopausal osteoporotic conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Immunology, Osteoimmunology & Immunoporosis Lab (TIOIL), Department of Biotechnology, All India Institute of Medical Sciences (AIIMS), New Delhi 110029, India.
- Department of Zoology, Dr. Harisingh Gour Vishwavidyalaya (Central University), Sagar 470003, India.
- Drug Development Laboratory, School of Vocational Studies and Applied Sciences, Gautam Buddha University, Greater Noida 201312, India.
- Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar 470003, India.
- Department of Molecular Biology, ICMR-NIREH, Bhopal 462001, India.
ORCID-Profile: Zaffar Azam, Niharika Sinha, Pradyumna K Mishra, Rupesh K Srivastava
Förderung
- DBT(BT/PR41958/MED/97/524/2021) Govt. of India
- UGC-New Delhi-India
Zitieren
APA
Azam, Z., Sapra, L., Baghel, K., Sinha, N., Gupta, R. K., Soni, V., Saini, C., Mishra, P. K., & Srivastava, R. K. (2023). Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System. Cells, 12(2), 216. https://doi.org/10.3390/cells12020216
Vancouver
Azam Z, Sapra L, Baghel K, Sinha N, Gupta RK, Soni V, et al. Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System. Cells. 2023;12(2):216. doi:10.3390/cells12020216
BibTeX
@article{Azam2023,
author = {Azam, Zaffar and Sapra, Leena and Baghel, Kalpana and Sinha, Niharika and Gupta, Rajesh K and Soni, Vandana and Saini, Chaman and Mishra, Pradyumna K and Srivastava, Rupesh K},
title = {Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System},
journal = {Cells},
year = {2023},
volume = {12},
number = {2},
pages = {216},
doi = {10.3390/cells12020216}
}
EUVIMED